Рет қаралды 7,816
Watch Dr ElNaggar discuss the clinical utility of homologous recombination deficiency (HRD) and how testing for HRD at diagnosis can help identify appropriate treatment options for advanced ovarian cancer patients.
Visit www.AZprecisionmed.com to learn more.